Literature DB >> 24615127

Bone marrow parasite burden among patients with New World kala-azar is associated with disease severity.

Joyce M Silva1, Danielle A Zacarias, Lívio C de Figueirêdo, Maria Regiane A Soares, Edna A Y Ishikawa, Dorcas L Costa, Carlos H N Costa.   

Abstract

Kala-azar or visceral leishmaniasis, found mostly throughout the Indian Subcontinent, East Africa, and Brazil, kills 20,000-40,000 persons annually. The agents, Leishmania donovani and Leishmania infantum, are obligatory intracellular protozoa of mononuclear phagocytes found principally in the spleen and bone marrow. Protracted fever, anemia, wasting, hepatosplenomegaly, hemorrhages, and bacterial co-infections are typical features. One hundred and twenty-two (122) in-hospital patients were studied to verify if higher bone marrow parasite load estimated by quantitative polymerase chain reaction is associated with severe disease. The estimated median parasite load was 5.0 parasites/10(6) human nucleated cells. It is much higher in deceased than among survivors (median 75.0 versus 4.2). Patients who lost more weight had a higher parasite burden, as well as patients with epistaxis, abdominal pain, edema, and jaundice. This study suggests that higher parasite load is influenced by wasting, which may lead to more severe disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24615127      PMCID: PMC3973504          DOI: 10.4269/ajtmh.13-0376

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  48 in total

Review 1.  Bone marrow aspiration.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 2.  Secreted virulence factors and immune evasion in visceral leishmaniasis.

Authors:  Ulrike Lambertz; Judith Maxwell Silverman; Devki Nandan; W Robert McMaster; Joachim Clos; Leonard J Foster; Neil E Reiner
Journal:  J Leukoc Biol       Date:  2012-03-21       Impact factor: 4.962

3.  IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis.

Authors:  Shalini Gautam; Rajiv Kumar; Radheshyam Maurya; Susanne Nylén; Nasim Ansari; Madhukar Rai; Shyam Sundar; David Sacks
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

Review 4.  Bone marrow and the control of immunity.

Authors:  Ende Zhao; Huanbin Xu; Lin Wang; Ilona Kryczek; Ke Wu; Yu Hu; Guobin Wang; Weiping Zou
Journal:  Cell Mol Immunol       Date:  2011-10-24       Impact factor: 11.530

5.  Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study.

Authors:  Carlos Henrique Nery Costa; Guilherme Loureiro Werneck; Dorcas Lamounier Costa; Thiago Ayres Holanda; Guilherme Brasileiro Aguiar; Aline Santos Carvalho; Janaína Costa Cavalcanti; Loryenne Santos Santos
Journal:  Rev Soc Bras Med Trop       Date:  2010 Jul-Aug       Impact factor: 1.581

6.  Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil.

Authors:  G L Werneck; M S A Batista; J R B Gomes; D L Costa; C H N Costa
Journal:  Infection       Date:  2003-06       Impact factor: 3.553

7.  Serum cytokines associated with severity and complications of kala-azar.

Authors:  Dorcas L Costa; Regina L Rocha; Rayssa M A Carvalho; Adelino S Lima-Neto; Michael O Harhay; Carlos Henrique N Costa; Manoel Barral-Neto; Aldina P Barral
Journal:  Pathog Glob Health       Date:  2013-03       Impact factor: 2.894

8.  Risk factors for death in children with visceral leishmaniasis.

Authors:  Márcia Jaqueline Alves de Queiroz Sampaio; Nara Vasconcelos Cavalcanti; João Guilherme Bezerra Alves; Mário Jorge Costa Fernandes Filho; Jailson B Correia
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

9.  Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.

Authors:  Joanna R Santos-Oliveira; Eduardo G Regis; Cássia R B Leal; Rivaldo V Cunha; Patrícia T Bozza; Alda M Da-Cruz
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

10.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more
  8 in total

Review 1.  Parasite-bacteria interrelationship.

Authors:  Dalia S Ashour; Ahmad A Othman
Journal:  Parasitol Res       Date:  2020-08-04       Impact factor: 2.289

2.  Imported visceral leishmaniasis - unexpected bone marrow diagnosis in a patient with fever, pancytopenia, and splenomegaly.

Authors:  Valentina Gallina; Raffaella Binazzi; Arber Golemi; Mohsen Farsad; Günter Weiss; Christian J Wiedermann
Journal:  Am J Blood Res       Date:  2014-12-15

Review 3.  Leishmania infection: painful or painless?

Authors:  Sergio M Borghi; Victor Fattori; Ivete Conchon-Costa; Phileno Pinge-Filho; Wander R Pavanelli; Waldiceu A Verri
Journal:  Parasitol Res       Date:  2016-12-09       Impact factor: 2.289

4.  The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.

Authors:  Priscila L Dos Santos; Fabrícia A de Oliveira; Micheli Luize B Santos; Luana Celina S Cunha; Michelle T B Lino; Michelle F S de Oliveira; Manuela O M Bomfim; Angela Maria Silva; Tatiana R de Moura; Amélia R de Jesus; Malcolm S Duthie; Steven G Reed; Roque P de Almeida
Journal:  PLoS Negl Trop Dis       Date:  2016-01-27

5.  Incidence of Mortality and Its Predictors Among Adult Visceral Leishmaniasis Patients at the University of Gondar Hospital: A Retrospective Cohort Study.

Authors:  Yigizie Yeshaw; Adino Tesfahun Tsegaye; Solomon Gedlu Nigatu
Journal:  Infect Drug Resist       Date:  2020-03-24       Impact factor: 4.003

6.  Tissue Specific Dual RNA-Seq Defines Host-Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum.

Authors:  Sarah Forrester; Amy Goundry; Bruna Torres Dias; Thyago Leal-Calvo; Milton Ozório Moraes; Paul M Kaye; Jeremy C Mottram; Ana Paula C A Lima
Journal:  Microbiol Spectr       Date:  2022-04-06

7.  A Multi-Country, Single-Blinded, Phase 2 Study to Evaluate a Point-of-Need System for Rapid Detection of Leishmaniasis and Its Implementation in Endemic Settings.

Authors:  Prakash Ghosh; Abhijit Sharma; Narayan Raj Bhattarai; Kumar Abhishek; Thilini Nisansala; Amresh Kumar; Susanne Böhlken-Fascher; Rajashree Chowdhury; Md Anik Ashfaq Khan; Khaledul Faisal; Faria Hossain; Md Rasel Uddin; Md Utba Rashid; Shomik Maruf; Keshav Rai; Monica Sooriyaarachchi; Withanage Lakma Kumari Abhayarathna; Prahlad Karki; Shiril Kumar; Shalindra Ranasinghe; Basudha Khanal; Satyabrata Routray; Pradeep Das; Dinesh Mondal; Ahmed Abd El Wahed
Journal:  Microorganisms       Date:  2021-03-12

Review 8.  Visualizing the In Vivo Dynamics of Anti-Leishmania Immunity: Discoveries and Challenges.

Authors:  Romaniya Zayats; Jude E Uzonna; Thomas T Murooka
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.